Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality
worldwide and its incidence continues to rise. While cirrhosis underlies most cases of HCC …

Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …

Several staging systems for hepatocellular carcinoma (HCC) have been developed. The
Barcelona Clinic Liver Cancer staging system is considered the best in predicting survival …

Many guidelines for hepatocellular carcinoma (HCC) have been published and updated
globally. In contrast to other cancers, there is a range of treatment options for HCC involving …

Traditional drugs or therapies rarely have effects on regression of chronic liver diseases,
which result in many cases from sustained oxidative stress. In recent years, ellagic acid (EA) …

Hepatocellular carcinoma (HCC) is a cause of several deaths related to cancer worldwidely.
In early stage, curative treatments such as surgical resection, liver transplant and local …

Hepatocellular carcinoma (HCC) is a common cancer and ranks sixth among all
malignancies worldwide. Risk factors for HCC can be classified as infectious or behavioral …

Hepatocellular carcinoma (HCC) is a major health concern worldwide and the third cause of
cancer-related death. Despite advances in treatment as well as careful surveillance …

Hepatocellular carcinoma (HCC) is a lethal malignancy with poor prognosis. More than 80%
of patients are diagnosed at an advanced stage, and most patients with HCC also have liver …

Hepatocellular carcinoma (HCC) is one of the most common malignancies leading to high
mortality rates in the general population; in cirrhotic patients, it is the primary cause of death …